Complete response of early gastric cancer to uracil and tegafur

被引:0
|
作者
Kazuya Akahoshi
Yoshiharu Chijiiwa
Syuji Hamada
Keiichi Hara
Kazuhiko Nakamura
Hajime Nawata
Noriaki Matsui
机构
[1] Third Department of Internal Medicine,
[2] Faculty of Medicine,undefined
[3] Kyushu University,undefined
[4] Fukuoka,undefined
[5] Japan,undefined
[6] Second Department of Pathology,undefined
[7] Faculty of Medicine,undefined
[8] Kyushu University,undefined
[9] Fukuoka,undefined
[10] Japan,undefined
来源
关键词
Key words: early gastric cancer; UFT; complete response;
D O I
暂无
中图分类号
学科分类号
摘要
A 74-year-old Japanese woman with early gastric cancer was successfully treated with uracil and tegafur (UFT). She was diagnosed by endoscopy (including endoscopic biopsy and endosonography) with an early gastric cancer, type IIa + IIc, on the greater curvature of the angulus. Surgical procedures or endoscopic therapy could not be performed because the patient had severe ischemic heart disease. Therefore, chemotherapy with UFT was administered at 300 mg/day for 15 months. Follow-up endoscopy, endosonography, and biopsy showed disappearance of the gastric cancer. To our knowledge, this is the first case report of the complete response of an early gastric cancer to UFT in the English-language literature.
引用
收藏
页码:864 / 867
页数:3
相关论文
共 50 条
  • [21] Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer
    Kanaji, Nobuhiro
    Bandoh, Shoji
    Ishida, Toshihiko
    SOUTHERN MEDICAL JOURNAL, 2007, 100 (10) : 1056 - 1057
  • [22] Erratum to Oral Tegafur/Uracil
    K Wellington
    K L Goa
    Drugs & Aging, 2002, 19 (5) : 363 - 363
  • [23] ASO Author Reflections: Tegafur–Uracil in Advanced Oral Cancer
    Ming-Yu Hsieh
    Mu-Kuan Chen
    Annals of Surgical Oncology, 2018, 25 : 899 - 900
  • [24] Benefit of Tegafur-Uracil and Leucovorin in Chemoradiotherapy for Rectal Cancer
    Ishihara, Soichiro
    Hayama, Tamuro
    Yamada, Hideki
    Nozawa, Keijiro
    Matsuda, Keiji
    Watanabe, Toshiahi
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 756 - 762
  • [25] Uracil-tegafur (UFT) based radiochemotherapy in adjuvant treatment of resected high risk gastric cancer.
    Gemici, C
    Demir, O
    Salepci, T
    Gumus, M
    Mayadagli, A
    Seseogullari, OO
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [26] Reduction in γ-Glutamyl Hydrolase Expression Is Associated with Response to Uracil and Tegafur/Leucovorin Chemotherapy in Patients with Colorectal Cancer
    Sadahiro, Sotaro
    Suzuki, Toshiyuki
    Tanaka, Akira
    Okada, Kazutake
    Kamijo, Akemi
    Nagase, Hideki
    Uchida, Junji
    ANTICANCER RESEARCH, 2013, 33 (08) : 3431 - 3438
  • [27] The Unusual Presentation of Gastric Adenocarcinoma as a Testicular Mass: A Favorable Response to Docetaxel and Cisplatin Plus Oral Tegafur/Uracil and Leucovorin
    Yang, Kai-Chung
    Chao, Yee
    Luo, Jiing-Chyuan
    Kuo, Junne-Yih
    Lee, Rheun-Chuan
    Li, Anna Fen-Yau
    Li, Chung-Pin
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2010, 73 (02) : 88 - 92
  • [28] Adjuvant chemotherapy with uracil-tegafur (UFT) for serosa negative advanced gastric cancer: Results of a randomized trial by national surgical adjuvant study of gastric cancer
    Kinoshita, T
    Nakajima, T
    Ohashi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 313S - 313S
  • [29] Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience
    Hung-Hsuan Yen
    Chiung-Nien Chen
    Chi-Chuan Yeh
    I-Rue Lai
    World Journal of Surgical Oncology, 19
  • [30] A randomized consent design trial of neoadjuvant chemotherapy with Tegafur plus uracil (UFT) for gastric cancer - A single institute study
    Nio, Y
    Koike, M
    Omori, H
    Hashimoto, K
    Itakura, M
    Yano, S
    Higami, T
    Maruyama, R
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1879 - 1887